Climb Bio Inc. Common Stock (CLYM)

About CLYM

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Website

climbbio.com/

Fundamentals

Market cap

$801.68M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-0.78

Dividend yield

—

Beta

-0.01

Avg. volume

—

Climb Bio Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• CLYM

  Climb Bio Inc. Common Stock

  $14.56

  ▼ 3.32%
  Market cap $801.68MP/E —
  $1.54$18.33
• MNPR

  Monopar Therapeutics Inc. Common Stock

  $112.17

  ▼ 1.55%
  Market cap $805.29MP/E —
  $32.77$124.82
• DRUG

  Bright Minds Biosciences Inc. Common Stock

  $72.74

  ▼ 2.41%
  Market cap $792.81MP/E —
  $53.99$170
• PHAR

  Pharming Group N.V. ADS each representing 10 ordinary shares

  $11.7

  ▼ 0.68%
  Market cap $766.28MP/E 88.15
  $0.8338$1.82
• ACRS

  Aclaris Therapeutics Inc. Common Stock

  $6.01

  ▼ 2.44%
  Market cap $850.55MP/E —
  $1.74$6.6
• DSGN

  Design Therapeutics Inc. Common Stock

  $15.12

  ▼ 0.85%
  Market cap $861.75MP/E —
  $5.04$17.25
• CYRX

  CryoPort Inc. Common Stock

  $16.08

  ▼ 2.96%
  Market cap $741.42MP/E —
  $7.61$17.2

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• HC Wainwright & Co. Maintains Buy on Climb Bio, Raises Price Target to $24
  benzinga · 8/24/2026
• HC Wainwright & Co. Maintains Buy on Climb Bio, Raises Price Target to $24
  Benzinga · 8/24/2026
• Wedbush Reiterates Outperform on Climb Bio, Maintains $20 Price Target
  Benzinga · 8/19/2026
• Truist Securities Maintains Buy on Climb Bio, Raises Price Target to $25
  Benzinga · 8/7/2026
• Climb Bio Q2 EPS $(0.18) Beats $(0.21) Estimate
  Benzinga · 8/6/2026

• Celebi Breanna Maurine · June 29, 2026 · Grant

  70.3K
• RA CAPITAL MANAGEMENT, L.P. · June 29, 2026 · Grant

  70.3K
• Levin Andrew David · June 5, 2026 · Grant

  40.0K
• Stephen Basil Thomas · June 5, 2026 · Grant

  40.0K
• Dunn Judith · June 5, 2026 · Grant

  40.0K
• Cumbo Alexander · June 5, 2026 · Grant

  40.0K
• Kimberlee C. Drapkin · June 5, 2026 · Grant

  40.0K
• RA Capital Healthcare Fund LP · June 5, 2026 · Grant

  40.0K
• WILLIAMS DOUGLAS E · June 5, 2026 · Grant

  40.0K
• RA Capital Healthcare Fund LP · April 29, 2026 · Grant

  2.11M @ $9.5

Institutional Ownership

March 31, 2026

Total shares held

32.21M

Total value held

$207.23M

Institutional holders

77